STATE-OF-THE-ART PAPER
Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases
Ara Tachjian, MD*,
Viqar Maria, MBBS* and
Arshad Jahangir, MD ,*
* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona
Manuscript received June 11, 2008;
accepted July 30, 2009.
* Reprint requests and correspondence: Dr. Arshad Jahangir, Division of Cardiovascular Diseases, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259 (Email: jahangir.arshad{at}mayo.edu).
More than 15 million people in the U.S. consume herbal remedies or high-dose vitamins. The number of visits to providers of complementary and alternative medicine exceeds those to primary care physicians, for annual out-of-pocket costs of $30 billion. Use of herbal products forms the bulk of treatments, particularly by elderly people who also consume multiple prescription medications for comorbid conditions, which increases the risk of adverse herb-drug-disease interactions. Despite the paucity of scientific evidence supporting the safety or efficacy of herbal products, their widespread promotion in the popular media and the unsubstantiated health care claims about their efficacy drive consumer demand. In this review, we highlight commonly used herbs and their interactions with cardiovascular drugs. We also discuss health-related issues of herbal products and suggest ways to improve their safety to better protect the public from untoward effects.
Key Words: cardiovascular agents • complementary therapies • drug approval • herbal medicine • herb–drug interaction
|
Abbreviations and Acronyms
| | BPH = benign prostatic hypertrophy | | CAM = complementary and alternative medicine | | CHF = congestive heart failure | | FDA = U.S. Food and Drug Administration |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A32.
[Full Text]
[PDF]
|
